Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression

NCT05749289 is registered in ClinicalTrials.gov with Cancer Institute and Hospital, Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT05749289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05749289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression
Lead sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase
Phase 2/3
Overall status
Recruiting
Start date
December 20, 2022
Completion date
December 20, 2029
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sstr positive tumors